115 related articles for article (PubMed ID: 2586573)
1. Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy.
Burke DS; Redfield RR; Bjornson DC; Fowler AK; Oster CN
N Engl J Med; 1989 Dec; 321(24):1682. PubMed ID: 2586573
[No Abstract] [Full Text] [Related]
2. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
Ho DD; Moudgil T; Alam M
N Engl J Med; 1989 Dec; 321(24):1621-5. PubMed ID: 2586564
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 isolation from small amounts of whole blood: a technical evaluation.
Fiore JR; Angarano G; Fico C; Di Stefano M; Grottola A; Monno L; Fracasso C; Pastore G
Microbiologica; 1992 Jan; 15(1):35-44. PubMed ID: 1556958
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
Dis Markers; 1990; 8(3):159-61. PubMed ID: 2125536
[No Abstract] [Full Text] [Related]
5. Comparative study of the isolation of human immunodeficiency virus from the lung and peripheral blood of AIDS patients.
Clarke JR; Williamson JD; Mitchell DM
J Med Virol; 1993 Mar; 39(3):196-9. PubMed ID: 8468563
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of human immunodeficiency virus in the blood.
N Engl J Med; 1990 May; 322(20):1466-9. PubMed ID: 2330015
[No Abstract] [Full Text] [Related]
7. [Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients].
Tamalet C; Puel J; Fleury H; Ferchal F; Agut H; Brun-Vezinet F; Botti G; Rouzioux C
Pathol Biol (Paris); 1993 Apr; 41(4):399-403. PubMed ID: 8233642
[TBL] [Abstract][Full Text] [Related]
8. AZT resistance in isolates of HIV.
Richman DD
Immunodefic Rev; 1991; 2(4):315-8. PubMed ID: 2059436
[TBL] [Abstract][Full Text] [Related]
9. Persistent low plasma levels of HIV-1 in patients on AZT therapy and its implications.
Camsonne R; Bustany P; Bigot MC; Pottier D; Moulin MA
Therapie; 1994; 49(2):146-7. PubMed ID: 7817343
[No Abstract] [Full Text] [Related]
10. The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study.
Ruffault A; Michelet C; Jacquelinet C; Guist'hau O; Genetet N; Bariou C; Colimon R; Cartier F
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):243-8. PubMed ID: 7788423
[TBL] [Abstract][Full Text] [Related]
11. [Resistance to azidothymidine in human immunodeficiency virus (HIV) infection].
Karmanov EV; Lukashov VV
Mol Biol (Mosk); 1994; 28(1):7-20. PubMed ID: 7511784
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
Colson ER; Horwitz RI; Bia FJ; Viscoli CM
Arch Intern Med; 1991 Apr; 151(4):709-13. PubMed ID: 2012453
[TBL] [Abstract][Full Text] [Related]
13. The use of growth hematopoietic factors in AIDS.
Groopman JE
Pathol Biol (Paris); 1992 Nov; 39(9):874-5. PubMed ID: 1371606
[No Abstract] [Full Text] [Related]
14. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.
Rinaldo CR; Liebmann JM; Huang XL; Fan Z; Al-Shboul Q; McMahon DK; Day RD; Riddler SA; Mellors JW
J Infect Dis; 1999 Feb; 179(2):329-36. PubMed ID: 9878015
[TBL] [Abstract][Full Text] [Related]
15. [Antiretroviral treatment. Present and future of the combinations].
Gatell-Artigas JM
Rev Neurol; 1996 Dec; 24(136):1627-31. PubMed ID: 9064189
[TBL] [Abstract][Full Text] [Related]
16. AIDS in 1988.
Gallo RC; Montagnier L
Sci Am; 1988 Oct; 259(4):41-8. PubMed ID: 3072672
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of zidovudine and concomitant inosine-pranobex in AIDS patients.
De Simone C; Ferrazzi M; Bitonti F; Falciano M; Tzantzoglou S; Delia S; Sorice F
Immunopharmacol Immunotoxicol; 1988; 10(4):437-41. PubMed ID: 2469710
[TBL] [Abstract][Full Text] [Related]
18. Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
Jackson JB
Pediatr AIDS HIV Infect; 1995 Dec; 6(6):358-9. PubMed ID: 11361462
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
Kaulen P; Pham DT; Baranowski E; Wollensak J
Ger J Ophthalmol; 1993 Nov; 2(6):412-5. PubMed ID: 8312826
[TBL] [Abstract][Full Text] [Related]
20. Zidovudine.
Powderly WG
Mo Med; 1989 Nov; 86(11):741-3. PubMed ID: 2682195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
